We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CTE market cap is 42.95M. The company's latest EPS is AUD 0.0377 and P/E is 23.34.
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 9.93M | 10.07M | 11.76M | 11.94M | 12.61M |
| Operating Income | 1.72M | 1.11M | 1.89M | 1.52M | 2.05M |
| Net Income | 1.48M | 653k | 1.36M | 1.41M | 1.84M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 23.5M | 21.99M | 21.5M | 22.65M | 19.71M |
| Total Liabilities | 23.79M | 21.62M | 19.64M | 19.87M | 18.26M |
| Total Equity | -287k | 378k | 1.86M | 2.78M | 1.45M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | 1.28M | 488k | 2.52M | 1.41M | 2.74M |
| Investing | -882k | -374k | -860k | -1.22M | 727k |
| Financing | -255k | -295k | -180k | -796k | -3.5M |
| Market Cap | 42.95M |
| Price to Earnings Ratio | 23.34 |
| Price to Sales Ratio | 3.41 |
| Price to Cash Ratio | 9.13 |
| Price to Book Ratio | 29.64 |
| Dividend Yield | - |
| Shares Outstanding | 48.81M |
| Average Volume (1 week) | 159.72k |
| Average Volume (1 Month) | 54.69k |
| 52 Week Change | 36.43% |
| 52 Week High | 1.25 |
| 52 Week Low | 0.55 |
| Spread (Intraday) | 0.3 (26.82%) |
| Company Name | Cryosite Limited |
| Address |
13a ferndell street, south granville sydney, new south wales 2142 |
| Website | https://www.cryosite.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
